Prenosis Inc: Valuation, Funding & Investors
Prenosis, Inc. is a biology-based technology company that develops integrated diagnostics and therapeutics for critical care conditions. The company leverages deep data and artificial intelligence through its Immunix platform to build AI-driven diagnostic tools and companion therapeutics, including the FDA-authorized Sepsis ImmunoScore, to enable precision medicine for sepsis, ARDS, AKI, pneumonia, and acute heart failure.
Leadership & Board
- Current Number of Employees
- 42
- Current LinkedIn Followers
- 4,652
Latest Estimated Valuation
- Total Amount Raised
- $20M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $20M
- Latest Funding Round
- Series A
Company Momentum Positive
Prenosis Inc LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Prenosis Inc had 42 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Prenosis Inc had 4,652 followers as of October 26, 2026. The number of followers increased by 11 (0.24%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jan 29, 2026 | Series A | $20.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Labcorp Venture Fund | Series A |
| UC Investments | Series A |
| Global Health Investment Corporation | Series A |
| PACE Healthcare Capital | Series A |
| UCI Health Ventures | Series A |
| Illinois Department of Commerce and Economic Opportunity | Series A |
| Carle Health | Series A |
Similar Companies
A snapshot of private companies similar to Prenosis Inc, helping you discover and navigate related company profiles.
Related News and Analysis
